GPs can access patient records via tablet devices
September 12, 2012Medical Communications Digital Blog, GPs, NHS, ipad
The first ever service allowing GPs to access and update their patient records using an iPad or other tablet device …
Pharma thumbs-up for government innovation centre
September 12, 2012Research and Development, Sales and Marketing ABPI, synthetic biology
The announcement of a new innovation and knowledge centre for synthetic biology has been welcomed by pharma groups.The new centre is part …
New frontiers in drug discovery
September 11, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing RNA, drug discovery, therapeutic
Despite the success of small molecule and biologic drugs such as monoclonal antibodies, there remain many areas of unmet medical …
Circassia appoints GSK’s Dr Brett Haumann
September 11, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brett Haumann, Circassia
Speciality biopharma firm Circassia has announced the appointment of Dr Brett Haumann as chief medical officer. Haumann joins allergy-focussed Circassia …
Merck releases new Phase III insomnia data
September 11, 2012Research and Development, Sales and Marketing Merck, insomnia, suvorexant
Merck says it is on course to file its investigational insomnia drug suvorexant in the US by the end of …
Patheon offloads clinical packaging ops
September 11, 2012Manufacturing and Production Bellwyck, Ontario, Patheon
Patheon has sold its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions as it continues …
Takeda opens Russian manufacturing facility
September 11, 2012Manufacturing and Production Actovegin, Nycomed, Russia, Takeda
Takeda Pharmaceutical has officially opened its new manufacturing facility in Yaroslavl, Russia, and expects it to be operating at full …
Rock appoints new associate director
September 11, 2012Business Services, Medical Communications, Sales and Marketing Laura Patel, Rock Medical Communications
ROCK medical communications has appointed Laura Patel as associate director. Patel has considerable experience in managing key medical education programmes, …
MedImmune signs China deal
September 11, 2012Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis
MedImmune has sealed a joint venture with Shanghai-based WuXi AppTec to develop a novel biologic for autoimmune and inflammatory diseases …
Ex-Pfizer head joins Red Door as International director
September 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Thomas, Pfizer, Red Door
Andrew Thomas the strategic communications lead for Pfizer’s primary care medicines across Europe and Canada joins Red Door Communications in …
Lilly suffers late-stage cancer blow
September 10, 2012Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology
Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …
Merck KGaA licences new cancer candidate
September 10, 2012Research and Development, Sales and Marketing Cancer, EGFR, Merck KGaA, oncology
Merck KGaA has signed a worldwide licence agreement with Danish company Symphogen which could expand its portfolio of drugs targeting …
Kantar appoints Graeme Jacombs head of APMEA region
September 7, 2012Sales and Marketing Kantar Health
Consultancy and market research firm Kantar Health has promoted Graeme Jacombs to Managing Director of the Asia Pacific, Middle East …
Boehringer signs diabetes research deal
September 7, 2012Sales and Marketing Boehringer, diabetes, obesity
Boehringer Ingelheim has signed a four-year research agreement with a top Swiss university to look at the underlying causes of …
Novartis to file for new Lucentis indication
September 7, 2012Lucentis, Novartis, macular edema, macular oedema, ophthamology
Novartis is set to file eye treatment Lucentis for a new indication. The firm will submit Lucentis (ranibizumab) to the …
New product launches – maximise your chance of success
September 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Paul Stuart Kregor, Paul Stuart-Kregor, marketing, product launch
You don’t have to look very far to see that the pharma industry business model is under increased pressure, and …
Brazil delays excipient GMP deadline
September 6, 2012Manufacturing and Production ANVISA, Brazil, GMP
Brazil’s national medicines regulatory agency ANVISA has delayed proposed new rules on good manufacturing practice (GMP) for pharmaceutical excipients after …
Hospira buys Indian antibiotic plant
September 6, 2012Manufacturing and Production Hospira, India
US injectable drugs specialist Hospira has announced plans to expand in India via the purchase of a manufacturing facility and …
Double approval for Pfizer cancer drugs
September 6, 2012Sales and Marketing CML, Cancer, Glivec, Pfizer, axitinib, rcc
Two cancer drugs from Pfizer have been approved, one in Europe for kidney cancer and another in the US for …
Merck KGaA cuts over 10% of German workforce
September 5, 2012Research and Development
Merck KGaA is to get rid of more than 10% of its workforce in Germany over the next three years …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
